Evidence map›Paper›PMID 30154863›Full record

ReviewStem cells international2018

Role of HOX Genes in Stem Cell Differentiation and Cancer.

Seema Bhatlekar, Jeremy Z Fields, Bruce M Boman

Open access · goldAbstract readReview
In one paragraph

Review in Stem cells international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 1 synthesis or guideline pooled it, 184 citations in OpenAlex.

  1. A Systematic Review onInternational journal of molecular sciences · 2021
    Pooled it
  2. Retinoic acid in health and disease.Signal transduction and targeted therapy · 2026
    Review
  3. Article
  4. Article
  5. Loss of long-range co-expression is a common feature in cancer.NPJ systems biology and applications · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Methylation-regulated tumor suppressor geneTranslational cancer research · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Biomolecules · 2025
    Review
  18. Review
  19. Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Seema BhatlekarCenter for Translational Cancer Research, Helen F. Graham Cancer Center and Research Institute, Newark, DE, USA.ORCID 0000-0003-1878-8353
Jeremy Z FieldsCATX Inc., Princeton, NJ, USA.
Bruce M BomanCenter for Translational Cancer Research, Helen F. Graham Cancer Center and Research Institute, Newark, DE, USA.ORCID 0000-0002-1335-9149
Center for Cancer Research · USThomas Jefferson University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HOX genes encode an evolutionarily conserved set of transcription factors that control how the phenotype of an organism becomes organized during development based on its genetic makeup. For example, in bilaterian-type animals, HOX genes are organized in gene clusters that encode anatomic segment identity, that is, whether the embryo will form with bilateral symmetry with a head (anterior), tail (posterior), back (dorsal), and belly (ventral). Although HOX genes are known to regulate stem cell (SC) differentiation and HOX genes are dysregulated in cancer, the mechanisms by which dysregulation of HOX genes in SCs causes cancer development is not fully understood. Therefore, the purpose of this manuscript was (i) to review the role of HOX genes in SC differentiation, particularly in embryonic, adult tissue-specific, and induced pluripotent SC, and (ii) to investigate how dysregulated HOX genes in SCs are responsible for the development of colorectal cancer (CRC) and acute myeloid leukemia (AML). We analyzed HOX gene expression in CRC and AML using information from The Cancer Genome Atlas study. Finally, we reviewed the literature on HOX genes and related therapeutics that might help us understand ways to develop SC-specific therapies that target aberrant HOX gene expression that contributes to cancer development.

Identifiers

PMID30154863
PMCPMC6081605
OpenAlexW2883936808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.